General Archive
-
News releasesLifeArc-founded RQ Bio secures £85.5 million to advance long-acting antibody for influenza prevention
The LifeArc-founded and backed biotech company RQ Bio has this week announced the completion of an oversubscribed $115 million (£85.5…
-
News releasesNew boost for personalised rare disease treatments as the Rare Therapies Launch Pad becomes part of LifeArc
We will be integrating the Rare Therapies Launch Pad (RTLP) into our organisation, marking an important next step in efforts…
-
News releasesWorld-first gene therapy to target devastating rare immune disorder
A first-of-its-kind gene therapy to treat people with CTLA-4 insufficiency, a rare and life-limiting inherited immune disorder, is being advanced…
-
News releasesLifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children
We have announced a new partnership with Elpida Therapeutics to support the development of three gene therapy programmes targeting ultra-rare…
-
News releasesFirst projects backed by C-Further consortium to develop better treatments for children with cancer
Children and young people diagnosed with aggressive cancers could benefit from potential new treatments from two pioneering projects led by…
-
News releasesFirst‑of‑its‑kind UK data initiative to boost early diagnosis and deliver better treatments for children with rare diseases
We are joining forces with Great Ormond Street Hospital (GOSH) on a data initiative – KidsRare – with the aim…
-
News releasesCould a nasal insulin spray improve the lives of children and young people living with a rare condition?
We are funding a new multi-million pound trial that will reveal if a simple nasal spray could improve daily life…
-
News releasesScientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin
A major international research project is underway to test whether a finger prick-style blood test could be used to help…
-
News releasesCould heart medication or arthritis drugs be used to treat motor neuron disease?
We have announced the launch of projects aimed at identifying repurposed drugs to treat motor neuron disease (MND), a devastating,…
-
News releasesAccelerating innovation to transform lung health in primary care
At this time of year as Winter beckons, many of us may come down with a respiratory virus or infection.…
-
News releasesLifeArc-funded trial gives new hope for children with devastating rare genetic disorder
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his…
-
News releasesBirmingham researchers lead world-first trial for rare liver disease treatment funded by LifeArc
University Hospitals Birmingham NHS Foundation Trust (UHB) has treated the first patient in an early-phase clinical trial investigating whether a…